ONCO today
$3.26-$0.50 (-13.30%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourSymmetric Triangle
1 hourSymmetric Triangle
15 minExpanding
5 minLeaning Bullish
Daily trend turns down below $0.38
Key levels
Resistance$22117.00
Resistance$7.82
Support$0.48
Latest news & SEC filings
DealOnco-Innovations Limited ends Sorbie financing deal tied to milestones
ProductEU regulator clears wider use for Pepaxti
DealRealbotix delays Onconetix deal closing until March 31, 2027
All ONCO news →About Onconetix
Onconetix is a biotech firm working in men's health and cancer. Its lead offering is Proclarix, a blood test that helps assess prostate cancer risk, sold in Europe and planned for U.S. launch as a lab-developed test via a LabCorp license. The company also had ENTADFI, an FDA-cleared pill for enlarged prostate, but has stopped selling it. Onconetix owns Proteomedix and uses outside manufacturers for its products.
Based on the company's 10-K filed Mar 13, 2026.
Nasdaq · Healthcare
Onconetix, Inc. (ONCO)
What Is the Price Target for ONCO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is ONCO a Buy or Sell Right Now?
Thesis
- •Revenue growing -67.7% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ONCO.
Start Free Trial →Is ONCO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG
Fair Value
$4834.69
40
Moat Score
NARROW
5/9
Piotroski Score
-9.8
Altman Z-Score
What Is Smart Money Doing with ONCO?
Insider Signal
NEUTRAL
3 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ONCO Growth Story
Revenue YoY
-67.7%
3yr Revenue CAGR
N/A%
EPS Growth YoY
99.09%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for ONCO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ONCO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:19:21 | $3.21 | 2,000 | $$6K | SELL |
| 15:04:35 | $3.47 | 1,300 | $$5K | SELL |
| 15:01:50 | $3.48 | 1,021 | $$4K | MIDPOINT |
| 14:59:06 | $3.45 | 1,300 | $$4K | SELL |
| 14:57:40 | $3.45 | 1,050 | $$4K | SELL |
5 dark pool trades shown · $$23K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Onconetix, Inc. (ONCO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ONCO — frequently asked questions
What is ONCO stock price today?
Onconetix, Inc. (ONCO) is at $3.26, down 13.30% (-$0.50) at the Nov 12, 2026 close.
Why is ONCO stock moving today?
Latest ONCO news — Nov 11, 2026: Onco-Innovations Limited ends Sorbie financing deal tied to milestones · Nov 10, 2026: EU regulator clears wider use for Pepaxti
Did ONCO beat earnings?
ONCO last reported on Aug 13, 2026: EPS -$1.28 vs -$4505.00 expected — a beat of 100.0%.
Does ONCO pay a dividend?
Yes. ONCO's dividend yield is 1.60%.
What are ONCO support and resistance levels?
Support: $0.48. Resistance: $7.82, $22117.00, $27574.00.
What are insiders doing with ONCO?
Insider activity: NEUTRAL, 3 buys and 2 sells in the last 90 days.
What is the latest news on ONCO?
Nov 11, 2026: Onco-Innovations Limited ends Sorbie financing deal tied to milestones · Nov 10, 2026: EU regulator clears wider use for Pepaxti · Nov 9, 2026: Realbotix delays Onconetix deal closing until March 31, 2027